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Analytical HPLC method
Method 3: Column = Phenomenex Luna 5 µm C 18 (2), 250 × 10 mm; Temperature = 25 °C Solvent A = H 2 O (0.1% formic acid); Solvent B = MeCN (0.1% formic acid); Flow Rate = 3.0 mL/min; Gradient: held at 5% B for 3 min, ramped to 20% B over 2 min, ramped to 60% B over 30 min, ramped to 95% B over 2 min, held at 95% B for 2 min, ramped to 5% B over 3 min and held for 5 min.
II.
General procedure for the synthesis of linear daptomycin derivatives Procedure A: To a solution of daptomycin-tetra-methyl ester derivative (2.5 mg, 1.5 µmol) in MeOH (200 µL) and MeCN (200 µL) at 0 ºC was added 43 mM NaOMe in MeOH (20 µL). The reaction mixture was stirred for 30 min. At this time, the reaction mixture was acidified using 1 M HCl(aq) to adjust the pH to 3.0. The reaction mixture was analyzed by LC-MS/MS to characterize the linear product of interest.
Procedure B: To a solution of daptomycin derivative (1.5 µmol) in H 2 O (200 µL) and MeCN (200 µL) at 0 ºC was added 1 M NaOH(aq) (~20 µL) to adjust the pH to 9 -9.5. The reaction mixture was stirred for 30 min. At this time, the reaction mixture was acidified using 1 M HCl(aq) to adjust the pH to 3.0. The reaction mixture was analyzed by LC-MS/MS to characterize the linear product of interest.
III. HPLC trace of tetra-methyl ester analog of daptomycin XIII. NMR spectra of tetra-modified daptomycin analogs All NMR experiments were performed on a 600 MHz Bruker Avance III NMR Spectrometer equipped with a 1.7 mm Cryo-TCI probe. The samples were inserted into the magnet using a SampleJet accessory.
To prepare the samples, approximately 1 mg of material was dissolved in 50 µL of DMSO-d 6 and bath sonicated for one minute to ensure proper dissolution before it was pipetted into the NMR tube. The tube was sealed with a plastic ball and was stored at room temperature prior to the experiments. All NMR experiments were performed at 298 K. All NMR data was processed using Mnova (MestReLab Research, Santiago de Compostela, Spain).
In order to obtain complete connectivities for the parent daptomycin, a standard 1 H NMR spectrum, a 1 H-1 H gCOSY spectrum, and a 1 H-1 H TOCSY spectrum were used to assign the individual spin systems. A two-dimensional 1 H-1 H NOESY experiment (150 msec mixing time) was used to confirm the sequential connectivities where possible. Finally, a 1 H-13 C gHSQC spectrum, a 1 H-13 C gHMBC spectrum, a 1 H-15 N fHSQC and a 1 H-15 N gHMBC were recorded. These enabled some resolution in cases where spectral overlap was an issue. Because of the apparent pH of the solution, the exchangeable amide protons were not observed in these experiments.
(1) Chemical shift assignment for the parent daptomycin (1) 
